Navigation Links
Stroke Study Reveals a Key Target For Improving Treatment
Date:6/22/2008

Research in mice shows why tPA carries risks as well as benefits, and suggests that Gleevec or other drugs could prevent problems

ANN ARBOR, Mich., June 22 /PRNewswire-USNewswire/ -- For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.

Now, a new paper published online in Nature Medicine reveals why tPA has these limitations. It also gives tantalizing evidence about how those problems might be overcome, if a stroke victim first takes a drug currently used to treat leukemia.

The researchers, from the University of Michigan and the Ludwig Institute for Cancer Research (LICR) Stockholm Branch at Karolinska Institutet in Stockholm, Sweden, emphasize that it's still too early to apply their findings -- made in mice -- to the treatment of stroke victims everywhere.

But the LICR-Karolinska Institutet team will soon begin a clinical trial to test the theory in humans, using the leukemia drug known as imatinib (Gleevec). In mice, that drug greatly reduced bleeding, even if tPA wasn't given until five hours after a stroke began.

The new paper details a series of molecular and cellular experiments conducted by the two teams, which began collaborating after hearing of each other's work.

They report that tPA apparently causes its risk of bleeding, and leakage of fluid within the brain, by accident. The culprit: tPA's tendency to act upon a protein called PDGF-CC, and the PDGF-alpha receptor that it binds to. This interaction causes the usually impervious "blood-brain barrier" to become porous, leading to leakage. Gleevec inhibits the PDGF-alpha receptor, apparently counteracting tPA's effect.

This unwanted effect on the blood-brain barrier appears to be unrelated to tPA's main job,
'/>"/>

SOURCE University of Michigan Health System
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
2. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
3. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
4. FASgen Announces New Discovery for Treatment of Stroke
5. ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. PRoFESS(R) Results Announced at XVII European Stroke Conference
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... N.J. , May 21, 2013  Armada ... launch of the new Armada corporate website ( ... clearly communicate Armada,s unique and first-to-market services and ... company focused on the specialty pharmacy industry. ... expansion of the Armada business model in delivering ...
(Date:5/21/2013)... , May 21, 2013  The North Shore-LIJ Health ... to measure hand-washing compliance at North Shore University Hospital ... cameras in operating rooms at Forest Hills ... ) The new pilot program strengthens patient ... operating rooms (ORs), the first time in the US ...
(Date:5/21/2013)... 21, 2013   Accuray Incorporated (Nasdaq: ... of study results involving hundreds of prostate cancer ... the most widely used form of prostate stereotactic ... patients for a median of 5 years, and ... 97 percent of patients with low-risk and 90.7% ...
Breaking Medicine Technology:Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
... of Red Ribbon Week, October 22-30, Gateway Foundation is ... abuse in the U.S., prescription drug abuse. As the ... Illinois , Gateway Foundation will build upon the Red ... by reaching out to parents and community leaders with ...
... -- The Institute of Health Sciences has ... Accrediting Bureau of Health Education Schools during the their ... the United States Secretary of Education for the accreditation ... predominantly allied health education programs and the programmatic accreditation ...
Cached Medicine Technology:Gateway Foundation Alcohol & Drug Treatment Honors Red Ribbon Week in October 2Gateway Foundation Alcohol & Drug Treatment Honors Red Ribbon Week in October 3Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education 2
(Date:5/21/2013)... the adenoids and tonsils, is performed 500,000 times a ... for children with obstructive sleep apnea. However, the ... functioning, behavior, sleep apnea symptoms, and quality of life ... study led by Susan Redline, MD, MPH, director ... Associate Clinic Director of the Division of Sleep Medicine ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Today, Zane ... HSA and FSA accounts. Zane Benefits, which provides ... benefits, is the leader in defined contribution ... arrangements . , According to Zane Benefits’ website, the ... was signed into law in 2010 and impacts many ...
(Date:5/21/2013)... Durham, NC (PRWEB) May 21, 2013 ... STEM CELLS Translational Medicine indicates that stem cells harvested ... from bone marrow in helping to modulate the body’s ... implications in developing new stem-cell-based therapies, as adipose tissue-derived ... body than those found in bone marrow and can ...
(Date:5/21/2013)... 21, 2013 Octo Consulting Group, ... management consulting solutions to the Federal marketplace, has ... In the newly created role, Denny will ... of the firm’s business development function to include ... functions, and leading strategies to achieve the firm’s ...
(Date:5/21/2013)... 21 (HealthDay News) -- Aggressive treatment for prostate ... patients with underlying medical conditions, a new study ... surgery, radiation and radioactive seed implants, can cause ... incontinence and bowel problems, explained researchers from the ... They found that older patients with slower growing ...
Breaking Medicine News(10 mins):Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2
... National Council of Legislators from Gaming States ( ... states with casinos and other forms of state-regulated ... encouraging states to take action to make all ... NCLGS 2009 Winter Meeting, held last weekend in ...
... CINCINNATI, Jan. 14 Kendle (Nasdaq: KNDL ... opening of a second office in western India in ... country and executing on its plans for,continued growth in ... India since 2004 and is targeting additional expansion in ...
... AMN Healthcare Services, Inc. (NYSE: AHS ), ... host its quarterly conference call to discuss fourth quarter and ... p.m. Eastern Time. The company expects to issue an ... the close of market at approximately 4:00 p.m. Eastern Time. ...
... HARRISBURG, Pa., Jan. 14 A surge of arctic ... bring hazardous wind chills that could lead to serious ... Pennsylvania are expected to range from the single digits ... drop to 5 to 30 below zero. "Taking preventive ...
... highlights:-- Cholesterol-lowering drug adherence drops with an increase ... for 90 straight days without medication was three ... group and twice as high in patients in ... exempt group (received prescriptions without a co-payment).-- Researchers ...
... WASHINGTON, Jan. 14 Edward Long, Ph.D., an expert ... Associates Inc., Washington,s largest independent government affairs firm."We,ve been ... Nobody in town knows more about health care research ... him join our firm and strengthen our health practice," ...
Cached Medicine News:Health News:National Council of Legislators From Gaming States Adopts Resolution Supporting 100% Smokefree Gaming Venues 2Health News:Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India 2Health News:Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India 3Health News:AMN Healthcare Services to Host 2008 Fourth Quarter & Year End Earnings Conference Call on Thursday, February 26, 2009 2Health News:Department of Health Urges Pennsylvanians to Prepare For Dangerously Cold Weather 2Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 2Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 3Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 4Health News:Dr. Edward Long Joins Van Scoyoc Associates 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: